Lung Injury and Infection

View posts, news, and publications related to our lung injury and infection research theme below.

Lifesaving HIV and Tuberculosis Medications

Dr. Dick Menzie’s team of PDFs contributed to a study in the Lancet on HIV and TB medications

Dr. Goldberg in La Presse – COVID-19 patients’ experiences post-ICU: enduring side effects and a long recovery.

Dr. Carolyn Baglole received a CIHR catalyst grant from the recent Health Effects of Vaping competition

Dr. Maziar Divangahi asserts that only a team effort across scientific disciplines will lead to the elimination of SARS-CoV-2.

Dr. Menzies was awarded the Canada Research Chair in Tuberculosis, Tier 1, in the Spring 2019 round.

Thanks to Adomo Donovan and the ICU Bridge Program, the MUHC’s ICU staff are now recognizable despite their PPE.

Dr. Menzies’ study found that 4-months of rifampin is a better course of treatment and more cost-effective for latent TB.

A new clinical trial, designed by Drs. Ezer, Martin, Benedetti & Smith, will test ciclesonide in the early stages of COVID-19.

Dr. Jean Bourbeau receives funding from the CIHR COVID-19 Rapid Research Funding Opportunity.

Read an opinion piece by Dr. Dick Menzies: How to focus testing and help eliminate the spread of COVID-19.